BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 38758695)

  • 1. An Improved PDE6D Inhibitor Combines with Sildenafil To Inhibit
    Kaya P; Schaffner-Reckinger E; Manoharan GB; Vukic V; Kiriazis A; Ledda M; Burgos Renedo M; Pavic K; Gaigneaux A; Glaab E; Abankwa DK
    J Med Chem; 2024 May; ():. PubMed ID: 38758695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PDE6D Inhibitors with a New Design Principle Selectively Block K-Ras Activity.
    Siddiqui FA; Alam C; Rosenqvist P; Ora M; Sabt A; Manoharan GB; Bindu L; Okutachi S; Catillon M; Taylor T; Abdelhafez OM; Lönnberg H; Stephen AG; Papageorgiou AC; Virta P; Abankwa D
    ACS Omega; 2020 Jan; 5(1):832-842. PubMed ID: 31956834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilization of the RAS:PDE6D Complex Is a Novel Strategy to Inhibit RAS Signaling.
    Yelland T; Garcia E; Parry C; Kowalczyk D; Wojnowska M; Gohlke A; Zalar M; Cameron K; Goodwin G; Yu Q; Zhu PC; ElMaghloob Y; Pugliese A; Archibald L; Jamieson A; Chen YX; McArthur D; Bower J; Ismail S
    J Med Chem; 2022 Feb; 65(3):1898-1914. PubMed ID: 35104933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Delta Subunit of Rod-Specific Photoreceptor cGMP Phosphodiesterase (PDE6D) Contributes to Hepatocellular Carcinoma Progression.
    Dietrich P; Hellerbrand C; Bosserhoff A
    Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30901922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AMPK and Endothelial Nitric Oxide Synthase Signaling Regulates K-Ras Plasma Membrane Interactions via Cyclic GMP-Dependent Protein Kinase 2.
    Cho KJ; Casteel DE; Prakash P; Tan L; van der Hoeven D; Salim AA; Kim C; Capon RJ; Lacey E; Cunha SR; Gorfe AA; Hancock JF
    Mol Cell Biol; 2016 Dec; 36(24):3086-3099. PubMed ID: 27697864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of PDE6D and CK1α Degraders through Chemical Derivatization of FPFT-2216.
    Teng M; Lu W; Donovan KA; Sun J; Krupnick NM; Nowak RP; Li YD; Sperling AS; Zhang T; Ebert BL; Fischer ES; Gray NS
    J Med Chem; 2022 Jan; 65(1):747-756. PubMed ID: 34965125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a new inhibitor of KRAS-PDEδ interaction targeting KRAS mutant nonsmall cell lung cancer.
    Leung EL; Luo LX; Li Y; Liu ZQ; Li LL; Shi DF; Xie Y; Huang M; Lu LL; Duan FG; Huang JM; Fan XX; Yuan ZW; Ding J; Yao XJ; Ward DC; Liu L
    Int J Cancer; 2019 Sep; 145(5):1334-1345. PubMed ID: 30786019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Pyridazinone Chemotypes Targeting the PDEδ Prenyl Binding Site.
    Murarka S; Martín-Gago P; Schultz-Fademrecht C; Al Saabi A; Baumann M; Fansa EK; Ismail S; Nussbaumer P; Wittinghofer A; Waldmann H
    Chemistry; 2017 May; 23(25):6083-6093. PubMed ID: 27809361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking the Farnesyl Pocket of PDEδ Reduces Rheb-Dependent mTORC1 Activation and Survival of
    Armijo ME; Escalona E; Peña D; Farias A; Morin V; Baumann M; Klebl BM; Pincheira R; Castro AF
    Front Pharmacol; 2022; 13():912688. PubMed ID: 35814251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of a small molecule inhibitor of PDE6D-RAS interaction with favorable anti-leukemic effects.
    Canovas Nunes S; De Vita S; Anighoro A; Autelitano F; Beaumont E; Klingbeil P; McGuinness M; Duvert B; Harris C; Yang L; Pokharel SP; Chen CW; Ermann M; Williams DA; Xu H
    Blood Cancer J; 2022 Apr; 12(4):64. PubMed ID: 35422065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecule inhibition of the KRAS-PDEδ interaction impairs oncogenic KRAS signalling.
    Zimmermann G; Papke B; Ismail S; Vartak N; Chandra A; Hoffmann M; Hahn SA; Triola G; Wittinghofer A; Bastiaens PI; Waldmann H
    Nature; 2013 May; 497(7451):638-42. PubMed ID: 23698361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promotion of cancer cell stemness by Ras.
    Chippalkatti R; Abankwa D
    Biochem Soc Trans; 2021 Feb; 49(1):467-476. PubMed ID: 33544116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A homozygous PDE6D mutation in Joubert syndrome impairs targeting of farnesylated INPP5E protein to the primary cilium.
    Thomas S; Wright KJ; Le Corre S; Micalizzi A; Romani M; Abhyankar A; Saada J; Perrault I; Amiel J; Litzler J; Filhol E; Elkhartoufi N; Kwong M; Casanova JL; Boddaert N; Baehr W; Lyonnet S; Munnich A; Burglen L; Chassaing N; Encha-Ravazi F; Vekemans M; Gleeson JG; Valente EM; Jackson PK; Drummond IA; Saunier S; Attié-Bitach T
    Hum Mutat; 2014 Jan; 35(1):137-46. PubMed ID: 24166846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EPHA2 feedback activation limits the response to PDEδ inhibition in KRAS-dependent cancer cells.
    Chen YH; Lv H; Shen N; Wang XM; Tang S; Xiong B; Ding J; Geng MY; Huang M
    Acta Pharmacol Sin; 2020 Feb; 41(2):270-277. PubMed ID: 31316177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure guided design and kinetic analysis of highly potent benzimidazole inhibitors targeting the PDEδ prenyl binding site.
    Zimmermann G; Schultz-Fademrecht C; Küchler P; Murarka S; Ismail S; Triola G; Nussbaumer P; Wittinghofer A; Waldmann H
    J Med Chem; 2014 Jun; 57(12):5435-48. PubMed ID: 24884780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploration of Novel PDEδ Inhibitor Based on Pharmacophore and Molecular Docking against KRAS Mutant in Colorectal Cancer.
    Mouhcine M; Kadil Y; Rahmoune I; Filali H
    Curr Drug Discov Technol; 2023; 20(4):e160423215830. PubMed ID: 37066770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PDEδ inhibition impedes the proliferation and survival of human colorectal cancer cell lines harboring oncogenic KRas.
    Klein CH; Truxius DC; Vogel HA; Harizanova J; Murarka S; Martín-Gago P; Bastiaens PIH
    Int J Cancer; 2019 Feb; 144(4):767-776. PubMed ID: 30194764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane protein transport in photoreceptors: the function of PDEδ: the Proctor lecture.
    Baehr W
    Invest Ophthalmol Vis Sci; 2014 Dec; 55(12):8653-66. PubMed ID: 25550383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based development of PDEδ inhibitors.
    Martín-Gago P; Fansa EK; Wittinghofer A; Waldmann H
    Biol Chem; 2017 May; 398(5-6):535-545. PubMed ID: 27935847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RPGR, a prenylated retinal ciliopathy protein, is targeted to cilia in a prenylation- and PDE6D-dependent manner.
    Dutta N; Seo S
    Biol Open; 2016 Sep; 5(9):1283-9. PubMed ID: 27493202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.